<DOC>
	<DOCNO>NCT01740986</DOCNO>
	<brief_summary>Clinical Study Evaluate Efficacy , Dose-response Safety SA09012 Bronchial Asthma Patients</brief_summary>
	<brief_title>Safety Efficacy SA09012 Asthma</brief_title>
	<detailed_description />
	<mesh_term>Asthma</mesh_term>
	<criteria>Diagnosis presence asthma within 3 month prestudy visit 1 . Increase PEF ≥ 20 % ≥ 60L/min baseline value take Bronchodilator screen within 3 month prestudy visit 2 . Increase FEV1 ≥ 12 % ≥ 200mL baseline value take Bronchodilator screen within 3 month prestudy visit FEV1 PEF 60 % 85 % predict value screen within 3 month prestudy visit Having sign informed consent Patient severe asthma Patient significant medical condition might compromise patient safety , interfere evaluation preclude completion study protocoldefined inclusion/exclusion criterion may apply Patient AST ALT &gt; 2x ULN ( upper limit normal ) screen visit Patient 10 pack year cigarettes history</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>79 Years</maximum_age>
	<verification_date>January 2015</verification_date>
	<keyword>Asthma</keyword>
</DOC>